Cite
He S, Zimmerman MW, Layden HM, et al. Synergistic melanoma cell death mediated by inhibition of both MCL1 and BCL2 in high-risk tumors driven by NF1/PTEN loss. Oncogene. 2021;40(38):5718-5729doi: 10.1038/s41388-021-01926-y.
He, S., Zimmerman, M. W., Layden, H. M., Berezovskaya, A., Etchin, J., Martel, M. W., Thurston, G., Jing, C. B., van Rooijen, E., Kaufman, C. K., Rodig, S. J., Zon, L. I., Patton, E. E., Mansour, M. R., & Look, A. T. (2021). Synergistic melanoma cell death mediated by inhibition of both MCL1 and BCL2 in high-risk tumors driven by NF1/PTEN loss. Oncogene, 40(38), 5718-5729. https://doi.org/10.1038/s41388-021-01926-y
He, Shuning, et al. "Synergistic melanoma cell death mediated by inhibition of both MCL1 and BCL2 in high-risk tumors driven by NF1/PTEN loss." Oncogene vol. 40,38 (2021): 5718-5729. doi: https://doi.org/10.1038/s41388-021-01926-y
He S, Zimmerman MW, Layden HM, Berezovskaya A, Etchin J, Martel MW, Thurston G, Jing CB, van Rooijen E, Kaufman CK, Rodig SJ, Zon LI, Patton EE, Mansour MR, Look AT. Synergistic melanoma cell death mediated by inhibition of both MCL1 and BCL2 in high-risk tumors driven by NF1/PTEN loss. Oncogene. 2021 Sep;40(38):5718-5729. doi: 10.1038/s41388-021-01926-y. Epub 2021 Jul 30. PMID: 34331013; PMCID: PMC8460449.
Copy
Download .nbib